With the combined goal of finding the best anti-parasitic and anti-cancer activities as well as isolating the bioactive agents and studying their structures and biological properties, we proceeded to perform a small-scale cultivation of Aspergillus sp. strain F1544 using Potato Dextrose, Malt Extract, Czapek Dox and Eight Vegetables media. From the more promising extracts (obtaining using potato dextrose and czapek dox media in large scale) of this fungus, we isolated the five compounds: pseurotin A (1), 14-norpseurotin A (2), FD-838 (3), and pseurotin D (4), and fumoquinone B (5). All compounds showed good antileishmanial and moderate anticancer activities.
The genus Aspergillus, one class of the most widely distributed endophytic fungi, is prolific producer of different types of important metabolites [1a] . This genus is a major producer of metabolites such as citric, gluconic, itaconic and kojic acid, which are very important from an industrial point of view [1a] . A second type of compounds of this genus is those which have certain pharmacological properties. Perhaps the most important are those belonging to the family of statins (cholesterol lowering compounds) and its derivatives [1a,1b] . In addition, we also find other compounds such as asperlicin, a cholecystokinin antagonist [1c], the alkaloid (+)-WIN 64821, a potent competitive substance P antagonist against the human neurokinin 1 and cholecystokinin type B receptors [1d], asperparalines, that are ion channel ligands, among others. A third group of compounds produced by Aspergillus are so-called mycotoxins, metabolites that are considered a serious problem in large part due to their prevalence in the biological deterioration of stored crops and as an opportunistic pathogen of field crops. Among these metabolites are aflatoxins, ochratoxin A, patulin and fumigillin [1a,1e] .
The endophytic fungus Aspergillus sp. strain F1544 was isolated from a mature leaf of Guapira standleyana (Nyctaginaceae), collected from the Coiba National Park in Panama. This isolated was identified tentatively on the basis of careful evaluation of sequence similarity to known species available through GenBank. A BLAST search revealed that Aspergillus sp. strain F1544 had an ITS1 sequence 100% identical with those of the type strain of Aspergillus sp. TMS-2011 voucher BGd1p19-4 (GenBank accession no. HQ631021.1).
Aspergillus sp. strain F1544 was cultivated in small scale using four different culture broths [Malt Extract (ME), Potato Dextrose (PD), Czapex Dox (CD), Eight Vegetables (8V)], and then, each of extracts was prepared by partition with Ethyl Acetate (EtOAc). The extracts obtained were tested for their anti-parasitic activity. Extracts prepared using CD and PD media showed good activity against L. donovani and MCF-7 cancer cell line, and extracts prepared with ME and 8V media showed moderate activity against the same parasites and cancer cell line. All extracts, with exception of the obtaining with CD medium, showed moderate activity against Malaria. Finally, none of the extracts was active against T. cruzi (Tables 1 and 3 ). According to these results, there is not a dependency between the biological activities that the fungus showed regarding the culture medium used to growth it, because when Aspergillus sp. strain F1544 was grown using a nutrient-rich medium (PD) the biological activity was similar than when the fungus was grown using nutrient-limited medium (CD).
Based on these results, we decided to conduct large-scale cultivations using CD and PD to check the secondary metabolites that the fungus produced in each culture media used.
In CD, the fungus was grown on 5 L of liquid medium, and then the obtained extract was fractionated by gravity column chromatography. Compound 1 was obtained by crystallization and Figure 1 ), by comparing their physicochemical properties with those reported.
Compounds 1−4 were tested for activity against three tropical disease parasites: L. donovani, T. cruzi and P. falciparum, and all compounds displayed activity against L. donovani (Table 2) . Compounds 2−4 showed moderate activity against P. falciparum, and none of the compounds showed activity against T. cruzi. Finally, all of the isolated compounds were evaluated for cytotoxicity to MCF-7 cells. All compounds showed moderate activity to MCF-7 cancer cells (Tables 2 and 3) .
Pseurotin A and related natural products have presented a wide variety of interesting activities, such as apomorphine-antagonistic, chitin synthase inhibitory activity, monoamine oxidase inhibitory activity, induction of cell differentiation, antifungal activity and synergistic activity with azole-type antifungal agents, antiangiogenic activity, and immunomodulation activity [2c,2d,2f].
However, there is no information about the antiparasitic activity of these compounds.
Later, we proceeded to grow the fungi in large-scale with PD (5L), and isolate the major compounds. From this extract, we obtained three compounds previously isolated from CD, pseurotin A, pseurotin D, and FD-838, additionally we obtained fumoquinone B (5) [3] .
Compound 5 was tested against three parasites (L. donovani, T. cruzi and P. falciparum) and a MCF-7 cancer cell line. This compound showed strong activity against L. donovani and moderate activity against P. falciparum and MCF-7 cancer cell line (Tables 2  and 3 ). All compounds showed good antileishmanial and moderate anticancer activities. For this reason, L. donovani could be a good target for future studies, focusing on finding the mechanism of action of them and discovering some derivatives with improved biological activity, more selective and less toxic.
In summary, Aspergillus sp. strain F1544 biosynthesizes compounds with an unusual hetero-spirocyclic ring system that contain a 1-oxa-7-azaspiro [4.4] non-2-ene-4,6-dione core. This type of compounds showed good antiparasitic and anticancer activity, and particularly presented strong activity against the parasite that causes leishmaniasis (L. donovani). Aspergillus sp. strain F1544 produced the same class of compounds both in a medium rich in nutrients (PD) as a medium limited in nutrients (CD). The yield and activity were similar in cultures made with PD and CD. Finally, the metabolites from Aspergillus sp. strain F1544 appear to be promising drug leads against L. donovani. For each, 0.5 L of sterile media was placed in 1 L capacity Erlenmeyer flasks, followed by inoculation with small pieces actively growing mycelium (0.5 cm 2 ). The cultures were incubated for 15 days at 30°C, under orbital agitation (150 rpm).
Experimental

Large scale cultures:
For CD or PD culture, ten 1 L Erlenmeyer flasks, each containing 0.5 L of liquid medium, were individually inoculated with a 1 cm 2 agar plug taken from a stock culture of Aspergillus sp. strain F1544 and placed on an orbital shaker at 150 rpm at 30 ºC for 15 days.
Production of extracts:
After incubation, the flasks were filtered through filters (Millipore) of. 0.45-p pore sizes. The filtrate was extracted exhaustively with ethyl acetate. The organic phase concentrated in vacuum to give the extracts. Mycelia was lyophilized and extracted with the same solvent.
Extraction and Isolation
Czapek 
Bioassays
In Leishmania bioassay, we employed axenically grown (cell free) amastigotes of L. donovani (LD-1S/MHOM/SD/00-strain1S). L. donovani is employed as it is the species responsible for the visceral and lethal form of the disease. The assay measures parasite growth and survival and employs PicoGreen. Samples for screening were originally tested in duplicate at a single concentration of 10 µg/mL. Results were expressed as percentage of parasite growth (% G) compared to control. Samples that showed 50% G or less were considered active and were then assayed at six concentrations (0.00032, 0.0016, 0.08, 0.4, 2, and 10 µg/mL) to determine IC 50 values. Amphotericin B was used as a positive control with the typical IC 50 response of L. donovani to this drug is between 70 and 120 ng/µL [4] .
Malaria bioassays were performed as previously reported by us, using chloroquine as a positive control (IC 50 = 80−100 nM) [5] . Chagas disease bioassays were performed following the protocol of Buckner et al. and using nifurtimox as a positive control (IC 50 = 3−5 μg/mL) [6] .
The cytotoxic activity against MCF-7 (human breast cancer cell line) was performed following the standard protocol of the National Cancer Institute [7] . All bioassays were performed in duplicate, testing at 10, 2, 0.4, 0.08, and 0.016 μg/mL.
